研究者業績

鈴木 啓太

suzuki keita

基本情報

所属
藤田医科大学 医学部 医学科 眼科学 講師
学位
博士(医学)

J-GLOBAL ID
201501017308217147
researchmap会員ID
7000013273

論文

 7
  • 小池晃央, 谷川篤宏, 水口忠, 杉本光生, 鈴木啓太, 堀口正之
    あたらしい眼科 38(6) 705-708 2021年  
  • Samoto D, Tanikawa A, Suzuki K, Tanaka H, Mizuguchi T, Shimada Y, Horiguchi M
    Fujita Medical Journal 7(4) 117-121 2021年  
  • Atsuhiro Tanikawa, Keita Suzuki, Ryoko Nomura, Hidenori Tanaka, Tadashi Mizuguchi, Yoshiaki Shimada, Masayuki Horiguchi
    Documenta Ophthalmologica 142(2) 177-183 2020年9月12日  
  • Keita Suzuki, Yoshiaki Shimada, Yui Seno, Tadashi Mizuguchi, Atsuhiro Tanikawa, Masayuki Horiguchi
    BMC Research Notes 11(1) 142 2018年2月20日  査読有り
    Objective: To determine the adherence to the face-down positioning (FDP) in 296 patients who had undergone vitrectomy and gas tamponade. Results: We studied 119 female and 177 male patients who had undergone primary vitrectomy and gas tamponade for a macular hole (MH) or for rhegmatogenous retinal detachments (RRDs). Adherence was assessed and recorded four times per day for 3 days postsurgery. The mean ± standard deviation adherence rate was 88.3 ± 11.7 (range 50.0-100.0). Female patients (90.8 ± 10.0) had significantly better adherence than male patients (86.7 ± 13.3 P &lt 0.02, U test). The adherence was significantly better after MH surgery (90.8 ± 11.7) than after RRD surgery (87.5 ± 12.5 P &lt 0.02). There were diurnal variations in adherence, being highest in the evening and significantly lower at midnight, and we evidenced a decline in adherence over time, with it being significantly low on the last follow-up day. Adherence to the FDP varied considerably among patients. Adherence was higher in female than in male patients, and higher in patients with MH than in those with RRD. We found patients age had no effect on adherence. Adherence also varied with time, being worst at midnight and declining over time.
  • Adherence to the, face-down, positioning after vitrectomy, gas tamponada, a, time series analysis
    BMC Res Notes 11(1) 142 2018年  査読有り
  • Shigeki Numata, Yohei Iwata, Rie Okumura, Masaru Arima, Tsukane Kobayashi, Soichiro Watanabe, Keita Suzuki, Masayuki Horiguchi, Kazumitsu Sugiura
    Journal of Dermatology 45(1) 113-114 2018年1月1日  査読有り
  • Keita Suzuki, Tadashi Mizuguchi, Yui Seno, Atsuhiro Tanikawa, Masayuki Horiguchi
    BMC OPHTHALMOLOGY 16(1) 155 2016年9月  査読有り
    Background: Iridocorneal endothelial (ICE) syndrome occurs mainly in young and middle-aged women and typically presents as a unilateral disease characterized by abnormalities of the iris and corneal endothelium. While the ICE syndrome is known to be associated with glaucoma and bullous keratopathy, to our knowledge, only two cases of ICE syndrome complicated with cystoid macular edema (CME) have been reported to date. In this paper, we report a case of ICE syndrome complicated with CME treated at our institution. Case presentation: The subject was a 51-year-old woman. In October 2013, she was examined by a primary care physician for blurred vision in her left eye. Dyscoria and abnormality of the corneal endothelium were observed, and the patient was diagnosed with ICE syndrome. In November of the same year, she was referred to our institution with a decrease in visual acuity and CME, both in her left eye. At initial examination, her best corrected decimal visual acuity was 1.0 (Snellen equivalent: 20/20) in the right eye and 0.5 (20/40) in the left eye. Intraocular pressure was 12 mmHg in both eyes. She was diagnosed with Cogan-Reese syndrome based on marked ectropion uveae, peripheral anterior synechia, and abnormalities of the corneal endothelium. Marked CME was observed on ophthalmoscopy and optical coherence tomography. A topical non-steroidal anti-inflammatory drug (nepafenac 0.1 %) was applied to the left eye four times daily from January 2014. Four weeks later, the CME had resolved and her visual acuity was 1.0 (20/20). Conclusion: While non-steroidal anti-inflammatory drugs and steroids did not appear to be effective in two previously reported cases of ICE syndrome complicated with CME, topical nepafenac was effective in this case. However, more such cases are needed before concluding that topical nepafenac is effective in this situation.

講演・口頭発表等

 13